Gremubamab Biosimilar Bispecific Antibody (PcrV × Pseudomonas Polysaccharide) for Research

Cat No.: GMP-Bios-ab-253

Pre-Made Gremubamab biosimilar, Bispecific mAb: Anti-PcrV type III secretion system; Polysaccharide synthesis locus (Pseudomonas) therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order Information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. →
Catalog No. Package Price(In USD)
GMP-Bios-ab-253-1mg 1mg
GMP-Bios-ab-253-10mg 10mg
GMP-Bios-ab-253-100mg 100mg
GMP-Bios-ab-253-xmg ≥100mg



Product Details

Products Name (INN Index) Pre-Made Gremubamab biosimilar, Bispecific mAb: Anti-PcrV type III secretion system; Polysaccharide synthesis locus (Pseudomonas) therapeutic antibody
INN Name Gremubamab
TargetPcrV type III secretion system;Polysaccharide synthesis locus (Pseudomonas)
FormatBispecific mAb
DerivationBispecific antibody
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa;Kappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusDiscontinued
100% SI StructureNone;None
99% SI StructureNone;None
95-98% SI StructureNone;None
Year Proposed2019
Year Recommended2020
CompaniesMedImmune
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedNosocomial pneumonia
Development Techna